TBPL2 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the TBPL2 protein, also known as TATA-box binding protein-like protein 2. TBPL2 is part of the TBP (TATA-box binding protein) family, which plays a crucial role in the initiation of transcription by RNA polymerase II. Unlike the canonical TBP, which is essential for general transcriptional activity in most genes, TBPL2 appears to be involved in more specialized transcriptional regulatory processes, particularly during specific stages of development. It is responsible for recruiting and stabilizing transcriptional machinery at the promoters of certain genes that lack the classic TATA-box, thus playing a key role in regulating gene expression in these contexts. By inhibiting TBPL2, these compounds disrupt the ability of the protein to assemble the transcriptional machinery, leading to changes in the expression of target genes.
Research on TBPL2 inhibitors offers valuable insights into the specialized roles of TBP-like proteins in transcriptional regulation. Inhibiting TBPL2 provides a means to study how the disruption of this protein impacts gene expression patterns, especially in genes that are uniquely regulated by this protein. Through TBPL2 inhibition, scientists can explore how TBPL2 influences the fine-tuning of transcription in specific tissues or developmental stages, helping to understand how alternative transcriptional mechanisms operate in different cellular contexts. Furthermore, TBPL2 inhibitors are important for dissecting the broader transcriptional networks that involve TBP-like proteins and their interactions with other transcription factors, co-factors, and regulatory elements. By studying these inhibitors, researchers can deepen their understanding of the complex regulation of gene expression and the role of TBPL2 in maintaining the specificity of transcriptional control in cells.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A kinase inhibitor that can suppress various kinases within signaling pathways, potentially affecting TBPL2's role in transcription regulation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can disrupt protein synthesis and potentially influence TBPL2 activity indirectly through cellular growth control mechanisms. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A phosphoinositide 3-kinase inhibitor that can alter signaling pathways, potentially modulating TBPL2's function. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An inhibitor of histone deacetylase that can change chromatin structure and influence transcription factor activities, including those related to TBPL2. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that can alter gene expression patterns, potentially impacting TBPL2's transcriptional activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor that can affect various signaling pathways, potentially altering TBPL2's activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of MEK, which is part of the MAPK pathway, could influence the activity of transcription factors and thereby TBPL2 indirectly. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor that can modulate transcription factor activity and potentially affect TBPL2's function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that can alter cytokine production and other signaling pathways, potentially affecting TBPL2's role. | ||||||
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $68.00 $312.00 | 2 | |
A cyclin-dependent kinase inhibitor that may affect the cell cycle and transcription factor activity related to TBPL2. | ||||||